民用航空人员肥厚型心肌病的诊断与鉴定  

Diagnosis and identification of hypertrophic cardiomyopathy in civil aviation personnel

作　　者：杨志勤[1] 杨仕云[1] Yang Zhiqin;Yang Shiyun(Aviation Hygiene Center of China Southern Airlines Co.Ltd.,Guangzhou,Guangdong 510406,China)

机构地区：[1]中国南方航空股份有限公司航空卫生中心,广州510406

出　　处：《中华航空航天医学杂志》2022年第4期235-239,共5页Chinese Journal of Aerospace Medicine

摘　　要：心血管疾病是民用航空人员停飞的最常见疾病,其中肥厚型心肌病是常见原因之一。民用航空人员肥厚型心肌病的患病率约1/2000,在我国亦有个案报道。肥厚型心肌病不但影响民用航空人员身体健康,亦对飞行安全带来极大隐患。笔者依据2020年肥厚型心肌病最新诊断和治疗指南就民用航空人员的健康管理提出意见和建议,以期对民用航空医学鉴定起到参考作用。Cardiovascular disease is the most common disease of grounding civil aviation personnel,and hypertrophic cardiomyopathy(HCM)is one of the most common disqualification reasons in civil aviation personnel.The prevalence of HCM is 1/2000 in civil aviation personnel and several cases were reported in our country.HCM not only affects the health of civil aviation personnel,but also brings considerable hidden dangers to flight safety.So,on the base of 2020 AHA/ACC guideline for the diagnosis and treatment of patients with HCM,the authors give views and advice on the health management of civil aviation personnel,to provide references for civil aviation medical identification.

关 键 词：心肌病 肥厚型 诊断 合格鉴定 民用航空人员 

分 类 号：R856.5[医药卫生—航空、航天与航海医学]